UMORE - Pharmacy
Program 2
Program 2: The Pharmaceutical and Healthcare Industry
Program 2 describes global health and health challenges that inform industry innovation to address global needs. It presents the R&D process of bringing medicines to the market and the pharmaceutical industry environment and government regulation. The program details the industry's role in the Australian healthcare system and how Australians gain access to medicines.
Program 2 is comprised of 6 modules and is estimated to take approximately 22 hours to complete.
Intended Learning Outcomes
- Understand demographic and economic factors that influence life expectancy in Australia and around the world
- Discuss health challenges, trends and goals in Australia and around the world
- Interpret health indicators and measures of disease impact
- Describe quality use of medicines and understand how these principles apply to stakeholders
- Describe the pharmaceutical industry environment internationally and within Australia
- Familiarise with the structure of the Australian healthcare system, funding and spending on health
- Understand how Australians access healthcare and medicines in Australia
- Explain the medicines approval process in Australia, distribution and monitoring
- Describe the contributions of the Australian pharmaceutical industry to health care and the Australian economy
- Identify the key legislative frameworks that govern the pharmaceutical industry in Australia
- Describe the process of developing a medicine and product life-cycle
Module Contents
In this Module we investigate life expectancy as one of the most frequently used health indicators and what influences the top causes of death across the globe. We answer questions such as: What are our world’s biggest health threats? And are we on track to a future with better health outcomes for all?
Australia's achievements in health include high life expectancy, a well-established universal health care system, strong regulatory capacity, demonstrated resilience to health security threats and global leadership in many areas of public health, such as tobacco control. This module investigates topics including our health system, life expectancy, health priorities, burden of disease and threats to Australian health.
This module examines Australia's healthcare system, the pharmaceutical industry’s crucial part of this system, and everything the industry does must fit within this system. The module covers Australia's health funding and its allocation, how healthcare is provided in Australia, and focus on medicines access including the Pharmaceutical Benefits Scheme.
This module introduces the structure of the pharmaceutical industry, discusses its current and future status, and considers the focus of research and development within the industry. The module looks more specifically at the Australian pharmaceutical industry and its contribution.
This module covers regulation of the pharmaceutical industry in Australia, The Therapeutic Goods Administration and the legislative frameworks including the Poisons standard.
Bringing a novel medicine to market is a long and rigorous process, typically progressing from a promising idea in the research laboratory through preclinical research and clinical trials, to a medicine receiving approval from regulators. This module looks into this process and what happens beyond market approval to complete the full life cycle of a medicine.
Video: CEP graduate Joshua Hogben talks about the value of studying Program 2. Duration 0:55.
For more information on this or other UMORE courses, and to enrol, sign up to our iLearn website.